Abstract
A brief review of important contributions to our present knowledge of growth hormone is given. In 1887 it had been noted that a pituitary tumor was present in most patients with acromegaly. Even at the beginning of the 20. Century relationship between growth disorders and the pituitary was contested. From 1908 pituitary surgery became established treatment in GH hypersecretion. In 1922 it was demonstrated that injection of pituitary extract to animals caused excessive growth and soon after the opposite: removal of the pituitary caused growth retardation. A huge number of studies on the effects of GH were subsequently reported as were trials with GH treatment. They were impeded by failure to recognize the impact of species specificity of GH. After this issue was clarified in 1957, treatment with human growth hormone proved effective. In 1985 it was realized that Creutzfeldt-Jakob’s disease might be transmitted through human growth hormone. At this time recombinant GH had become available. In 1971 the structure of human GH was established. In the same period both GH releasing and inhibiting hormones were identified and an analogue of somatostatin had evolved into the first effective pharmacological treatment for acromegaly.
Similar content being viewed by others
References
Minkowski O (1887) Ueber einen Fall von Akromegalie. Berlin klin Wochenschr 24:371–374
Saucerotte N (1931) Accroissement singulier en grosseur des os d’un homme agé 39 ans. Observation communiquee a l’Academie de Chirurgie en 1772. Melanges de chirurgie. 1801;1:1407–1411. Cit. by Weinberg SJ (1931). Gigantism and acromegaly. Ann med Hist 3:650-676
Fawcett E. Patrick Cotter (1909) — the Irish giant. J Roy Anthropol Inst 39:196–209
Keith A (1911) An inquiry into the nature of the skeletal changes in acromegaly. Lancet 1:993–1102
Fritsche CF, Klebs E (1884) Ein Beitrag zur Pathologie des Riesenwuchses. Vogel, Leipzig
Marie P (1886) Sur deux cas d’acromegalie. Rev Med 6:297–333
Lewis DD (1905) Hyperplasia of the chromophile cells of the hypophysis as the cause of acromegaly, with report of a case. Bull Johns Hopkins Hosp 16:157–164
Stumme E Akromegalie und Hypophyse(1908) Arch klin Chir 87:437–466
Caton R, Paul FT (1893) Notes of a case of acromegaly treated by operation. Br Med J 2:1421–1423.
Schloffer, H (1907) Erfolgreiche Operation eines Hypophysentumors auf nasalem Wege. Wien klin Wochenschr 20:621–624
Cushing H (1909) Partial hypophysectomy for acromegaly. Ann Surg 50:1002–1017
Krause F (1927) Bemerkungen zur Operation der Hypophysengeschwülste. Dtsch med Wochenschr 53:691–694
Evans HM, Long JA (1922) Characteristic effects upon growth, oestrus, and ovulation induced by the intraperitoneal administration of fresh anterior hypophyseal substance. Proc Natl Acad Sci 8:38–39
Smith PE (1927) The disabilities caused by hypophysectomy and their repair. J Am Med Ass 88:158–161
Borchardt L (1908) Die Hypophysenglykosurie und ihre Beziehungen zum Diabetes bei der Akromegalie. Z klin Med 66:332–348
Houssay BA, Biasotti A (1931) The hypophysis, carbohydrate metabolism and diabetes. Endocrinology 15:511–523
Petersen P, Lindholm J (1985) Pituitary apoplexy, the Houssay phenomenon and accelerated proliferative retinopathy. Am J Med 79:385–388
Astwood EB (1955) In: (Pincus G, Thiemann KV ed.) The Hormones, Academic Press, New York, vol. III pp. 235–308
Ketterer B, Randle PJ, Young FG (1957) The pituitary growth hormone and metabolic processes. Ergeb Physiol 49:127–211
Li CH, Evans HM (1944) The isolation of pituitary growth hormone. Science 99:183–184
Li CH, Papkoff A (1956) Preparation and properties of growth hormone from human and monkey pituitary glands. Science 124:1293–1294
Li CH, Dixon JS, Liu WK (1969) Human pituitary growth hormone. XIX. The primary structure of the hormone. Arch Biochem Biophys 133:70–91
Li CH, Dixon JS (1971) Human pituitary growth hormone XXXII. The primary structure of the hormone: Revision. Arch Biochem Biophys 146:233–236
Niall HD, Hogan ML, Tregear GW, Segre GV, Hwang P, Friesen H (1973) The chemistry of growth hormone and the lactogenic hormone. Recent Progr Horm Res 29:387–416
Li CH, Yamashiro D (1970) The synthesis of a protein possessing growth-promoting and lactogenic action. J Am Chem Soc 92:7608–7609
Salmon WD, Daughaday WH (1957) A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49:825–836
Rinderknecht E, Humbel R (1978) The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 253:2769–2776
Schoenle E, Zapf J, Humbel RE, Froesch ER (1982) Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature 296:252–253
Evans HM, Simpson ME, Marx W, Kibrick EA (1943) Bioassay of pituitary growth hormone. Width of proximal ephiphysial cartilage of tibia in hypophysectomized rats. Endocrinology 32:13–16
Glick SM, Roth J, Yalow RS, Berson SA (1963) Immunoassay of human growth hormone. Nature 199:784–787
Furlanetto RW, Underwood L, Van Wyk JJ, d’Ercole AJ (1977) Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest 60:648–657
Engelbach W (1932) The growth hormone. Endocrinology 16:1–19
Bennett LL, Weinberger H, Escamilla R, Margen S, Li CH, Evans HM (1950) Failure of hypophysial growth hormone to produce nitrogen storage in a girl with hypophysial dwarfism. J Clin Endocrinol Metabol 10:492–495
Escamilla RF, Bennett L (1951) Pituitary infantilism treated with purified growth hormone, thyroid and sublingual methyltestosterone. A case report. J Clin Endocrinol Metabol 11:221–228
Sayers G, Brown RW (1959) Glandular physiology and therapy. 5th edn, 1954, Lippincott, Philadelphia. Cit by Raben MS. Human growth hormone. Recent Progr Hor Res 15:71–114
Knobil E, Wolf RC, Greep RO, Wilhelmi AE (1957) Effect of primate pituitary growth hormone preparation on nitrogen metabolism in the hypophysectomized rhesus monkey. Endocrinology 60:166–168
Raben MS (1958) Treatment of pituitary dwarf with human growth hormone. J Clin Endocrinol Metabol 18:901–903
Beck JC, McGarry EE, Dyrenfurth I, Morgan RO, Bird ED, Venning EH (1960) Primate growth hormone studies in man. Metabolism 9:699–735
Cronin MJ (1997) Pioneering recombinant growth hormone manufacturing: pounds produced per mile of height. J Pediat 131:55–57
Koch TK, Berg BO, de Armand SJ, Gravina RF (1985) Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism: Possible relationship to administration of cadaveric human growth hormone. N Engl J Med 313:731–733
Mills JL, Schonberger LB, Wysowski DK, Brown P, Durako SJ, Cox C, Kong F, Fradkin JE (2004) Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. J Pediat 144:430–436
Laron Z (2004) Laron syndrome (primary growth hormone resistance or insensitivity): The personal experience 1958–2003. J Clin Endocrinol Metab 89:1031–1044
Woods KA, Camacho-Hübner C, Savage MO, Clark AJL (1996) Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor 1 gene. N Engl J Med 335:1363–1367
Reichlin S (1961) Growth hormone content of pituitaries from rats with hypothalamic lesions. Endocrinology 69:225–230
Krulich L, McCann SM (1969) Effect of GH-releasing and GH-inhibiting factor on the release and concentration of GH in pituitaries incubated in vitro. Endocrinology 85:319–324
Brazeau P, Vale W, Borgus R, Ling N, Butcher M, Rivier J, Guillemin R (1973) Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179:77–79
Hall R, Schally AV, Evered D, Kastin AJ, Mortimer CH, Tunbridge WMG, Besser GM, Coy DH, Goldie DJ, McNeilly AS, Phenekos C, Weightman D (1973) Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. Lancet 2:581–584
Plewe G, Krause U, Beyer J, Neufeld M, del Pozo E (1984) Long-acting and selective suppression of growth hormone secretion by somatostatin analogue SMS 201-995 in acromegaly. Lancet 2:782–784.
Dabek JT (1974) Bronchial carcinoid tumor with acromegaly in two patients. J Clin Endocrinol Metab 38:329–333
Scheithauer BW, Carpenter PC, Bloch B, Brazeau P (1984) Ectopic secretion of a growth hormone-releasing factor. Am J Med 76:605–616
Deuben RR, Meites J (1964) Stimulation of pituitary growth hormone release by a hypothalamic extract in vitro. Endocrinology 74:408–414
Schally AV, Steelman SL, Bowers CY (1965) Effect of hypothalamic extracts on release of growth hormone. Proc Soc Exp Biol Med 119:208–212
Frohman LA, Szabo M, Berelowitz M, Stachura ME (1980) Partial purification and characterization of a peptide with growth hormone-releasing activity from extrapituitary tumors in patients with acromegaly. J Clin Invest 65:43–54
Thorner MO, Perryman RL, Cronin MJ, Rogol AD, Draznin M, Johanson A, Vale W, Horvath E, Kovacs K (1982) Somatroph hyperplasia. J Clin Invest 70:965–977
Sassolas G, Chayvialle JA; Partensky C, Berger G, Trouillas J, Berger F, Claustrat B, Cohen R, Girod V, Guillemin R (1983) Acromegaly, clinical expression of the production of growth hormone releasing factor in pancreatic tumors. Ann Endocrinol 44:347–354
Rivier J, Spiess J, Thorner M, Vale W (1982) Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 300:276–278
Guillemin R, Brazeau P, Böhlen P, Esch F, Ling N, Wehrenberg WB (1982) Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 218:585–587
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lindholm, J. Growth hormone: Historical notes. Pituitary 9, 5–10 (2006). https://doi.org/10.1007/s11102-006-7557-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-006-7557-4